BiotechTube
Home/BinDeBio/Li Jing
LJ

Li Jing

President, Shenzhen BinDeBio

BinDeBio

Therapeutic Areas

OncologyImmunology

BinDeBio Pipeline

DrugIndicationPhase
CD19 CAR-TB-cell LymphomaClinical

Leadership Team at BinDeBio

SC
Sui Changjiang
Head, Shenyang BinDeBio
View full BinDeBio profile